No Data
No Data
10-K: FY2024 Annual Report
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Medicus Pharma Secures $4.2 Million for Innovative Skin Treatment Trials
Medicus Pharma Ltd: Promising Phase 2 Results and Market Potential Drive Buy Rating
Medicus Pharma Unveils Pricing of Financing to Advance Skin Cancer Treatment | NASDAQ:MDCX
Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
MIKEA5799 : we miss this for a while ago
.Thanks
EdwardChoo93 : gonna pump ?